Position in JNJ
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$910,990
+$57,895 QoQ
Shares Held
3,587
+2.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.71%
of 13F equity value
Holder Rank
#3,097
of 4,664 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Aspen Wealth Management LLC holds $3,231,331 across 5 Drug Manufacturers - General names. JNJ ranks #1 (28.2% of the industry book) .
All Filings in JNJ
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $910,990 | 3,587 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $853,095 | 3,490 | Shares | Sole | 2026-04-01 | |
| 2025-12-31 | $709,010 | 3,426 | Shares | Sole | 2026-01-05 | |
| 2025-09-30 | $586,483 | 3,163 | Shares | Sole | 2025-10-02 | |
| 2025-06-30 | $482,537 | 3,159 | Shares | Sole | 2025-07-02 | |
| 2025-03-31 | $521,898 | 3,147 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $453,672 | 3,137 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $578,392 | 3,569 | Shares | Sole | 2024-10-08 | |
| 2024-06-30 | $538,014 | 3,681 | Shares | Sole | 2024-07-10 | |
| 2024-03-31 | $609,664 | 3,854 | Shares | Sole | 2024-04-17 | |
| 2023-12-31 | $642,634 | 4,100 | Shares | Sole | 2024-01-16 | |
| 2023-09-30 | $638,419 | 4,099 | Shares | Sole | 2023-10-30 | |
| 2023-06-30 | $695,846 | 4,204 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $633,640 | 4,088 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $714,019 | 4,042 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $705,061 | 4,316 | Shares | Sole | 2022-10-11 | |
| 2022-06-30 | $674,360 | 3,799 | Shares | Sole | 2022-07-26 | |
| 2022-03-31 | $690,665 | 3,897 | Shares | Sole | 2022-04-27 | |
| 2021-12-31 | $666,659 | 3,897 | Shares | Sole | 2022-01-26 | |
| No filing history on record for this holder in this stock. | ||||||